JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
JOHNSON & JOHNSON
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026
$253.79−1.77 (-0.69%)
Close on Oct 19, 2026
- Market cap
- $619.27B
- P/E (TTM)
- 29.4
- Dividend yield
- 2.03%
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jun 13, 2001 | 2-for-1 | Earlier per-share figures divided by 2 |
| Jun 12, 1996 | 2-for-1 | Earlier per-share figures divided by 2 |
| Jun 10, 1992 | 2-for-1 | Earlier per-share figures divided by 2 |
| May 11, 1989 | 2-for-1 | Earlier per-share figures divided by 2 |
| May 19, 1981 | 3-for-1 | Earlier per-share figures divided by 3 |
| May 18, 1970 | 3-for-1 | Earlier per-share figures divided by 3 |
| Jun 19, 1967 | 3-for-1 | Earlier per-share figures divided by 3 |